| Website | vivaldibioscience... |
| Category | BioTech |
| Phone | 646-381-6680 |
| Employees | |
| Founded | 2006 |
| Description | develops influenza vaccines |
| TOTAL | $2M |
| VENTURE FUNDING TOTAL | $2M |
| Series A, 5/07 Bay City Capital | $2M |
Vivaldi Biosciences Inc. develops influenza vaccines and therapeutics for seasonal and pandemic influenza through a small molecule program targeting the NS1 protein of influenza. The company was founded in 2006 and is based in San Francisco, California.
